1-8 of 8
Nathan Punwani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced overall survival in TP53-mutated ccus is driven by prior cytotoxic exposure and cytopenia rather than leukemic progression

Free
Steven Tessier, Yazan Jabban, Hassan Alkhateeb, William Hogan, Mrinal Patnaik, Laura Ongie, Antoine Saliba, Abhishek Mangaonkar, Naseema Gangat, James Foran, Talha Badar, Hemant Murthy, Cecilia Arana Yi, Nathan Punwani, Yael Kusne, Kebede Begna, Ayalew Tefferi, Devendra Hiwase, Aref Al-Kali, Mithun Shah
Journal: Blood
Blood (2025) 146 (Supplement 1): 5643.
https://doi.org/10.1182/blood-2025-5643
Published: 2025
Journal Articles

Real world test characteristics of mass spectrometry monoclonal protein monitoring in multiple myeloma

Free
Kevin Shim, Mariano Arribas, Fabio Samir Vargas Cely, Udit Yadav, J Wiedmeier-Nutor, Nathan Punwani, Gabriela Alatorre, Sharene Best, Katalin Kelemen, Saurabh Chhabra, P. Leif Bergsagel, David Murray, Rafael Fonseca
Journal: Blood
Blood (2025) 146 (Supplement 1): 2201.
https://doi.org/10.1182/blood-2025-2201
Published: 2025
Journal Articles

Safety and efficacy of post transplant cyclophosphamide vs tacrolimus plus methotrexate for gvhd prophylaxis in myelofibrosis

Free
Usman Ilyas, Carolyn Mead-Harvey, Yenny Moreno Vanegas, Muhammad Abdullah Humayun, Kanishka Uttam Chandani, Diana Zamora Quintanilla, Ernesto Ayala, Saurabh Chhabra, James Foran, Talal Hilal, Madiha Iqbal, Mohamed Kharfan-Dabaja, Nandita Khera, Jose Leis, Hemant Murthy, Nathan Punwani, Vivek Roy, Lisa Sproat, Jeanne Palmer
Journal: Blood
Blood (2025) 146 (Supplement 1): 6016.
https://doi.org/10.1182/blood-2025-6016
Published: 2025
Journal Articles

Risk-adjusted comparison of survival in chronic myelomonocytic leukemia with and without allogeneic stem cell transplant: Mayo Clinic experience in 775 consecutive patients

Free
Ali Alsugair, Saubia Fathima, Mohammad Alhousani, Estefania Gauto Mariotti, Priyansh Faldu, Muhammad Yousuf, Abiola Bolarinwa, Clifford Csizmar, James Foran, Abhishek Mangaonkar, Mark Litzow, Hemant Murthy, Lisa Sproat, Jeanne Palmer, Aasiya Matin, Ernesto Ayala, James Slack, Luis Porrata, Madiha Iqbal, Nandita Khera, Nathan Punwani, Saad Kenderian, Saurabh Chhabra, Kebede Begna, Animesh Pardanani, William Hogan, Mithun Shah, Hassan Alkhateeb, Naseema Gangat, Mrinal Patnaik, Ayalew Tefferi
Journal: Blood
Blood (2025) 146 (Supplement 1): 5636.
https://doi.org/10.1182/blood-2025-5636
Published: 2025
Journal Articles

Clinical outcomes in adult AML with KMT2A rearrangements: A comparative analysis with R/R KMT2Ar and NPM1-mutated AML from the Mayo Clinic

Free
Mahmood Aldapt, Kin Fentie, Joseph Parker, Hemant Murthy, James Foran, Naseema Gangat, Mohamed Kharfan-Dabaja, Jennifer Jiang, Yao-Shan Fan, Aref Al-Kali, Antoine Saliba, Cecilia Arana Yi, Nathan Punwani, Lisa Sproat, Mark Litzow, Mrinal Patnaik, Talha Badar
Journal: Blood
Blood (2025) 146 (Supplement 1): 7030.
https://doi.org/10.1182/blood-2025-7030
Published: 2025
Journal Articles

Integrated prognostic model for TP53‑mutated myeloid neoplasms across all myeloid neoplasm subtypes

Free
Devendra Hiwase, Steven Tessier, Kevin Hung, Rong He, Maymona Abdelmagid, Danielle Rud, Michelle Maritz, Aref Al-Kali, Naseema Gangat, Mrinal Patnaik, Abhishek Mangaonkar, Hosein Anani, Antoine Saliba, Nathan Punwani, James Foran, Dong Chen, Emmanuel Gnanamanickam, Hassan Alkhateeb, Dariusz Ladon, Monika Kutyna, Kebede Begna, Hamish Scott, Mehrdad Hefazi Torghabeh, Aasiya Matin, Kaaren Reichard, Cinthya Zepeda, Chris Hahn, William Hogan, Attilio Orazi, Daniel Arber, Chung Hoow Kok, Mithun Shah, Ayalew Tefferi
Journal: Blood
Blood (2025) 146 (Supplement 1): 2087.
https://doi.org/10.1182/blood-2025-2087
Published: 2025
Journal Articles

CPX-351 versus venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia: A comparative analysis of outcomes in 600 patients

Free
Saubia Fathima, Lior Rokach, Nour Ghosoun, Mahsa Rezasoltani, Ali Alsugair, Kristen McCullough, Maymona Abdelmagid, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek Mangaonkar, Aasiya Matin, Antoine Saliba, Mehrdad Hefazi Torghabeh, Mark Litzow, William Hogan, Mithun Shah, Mrinal Patnaik, Animesh Pardanani, Talha Badar, Hemant Murthy, James Foran, Jeanne Palmer, Nathan Punwani, Lisa Sproat, Nandita Khera, Cecilia Arana Yi, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2025) 146 (Supplement 1): 1602.
https://doi.org/10.1182/blood-2025-1602
Published: 2025
Journal Articles

Phase I Results of a Multicenter Clinical Trial Combining Guadecitabine, a DNA Methyltransferase Inhibitor, with Atezolizumab, an Immune Checkpoint Inhibitor, in Patients with Relapsed or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Free
Casey L. O'Connell, MD, Patricia L. Kropf, MD, Nathan Punwani, MD MPH, Dan Rogers, CCRC, CIP, Richard Sposto, PhD, Kirsten Grønbæk, Professor, MD DMSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 1811.
https://doi.org/10.1182/blood-2018-99-117658
Published: 2018